Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
August-2014 Volume 45 Issue 2

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2014 Volume 45 Issue 2

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The anticancer effect and mechanism of α-hederin on breast cancer cells

  • Authors:
    • Lin Cheng
    • Tian-Song Xia
    • Yi-Fen Wang
    • Wenbin Zhou
    • Xiu-Qing Liang
    • Jin-Qiu Xue
    • Liang Shi
    • Ying Wang
    • Qiang Ding
    • Minhai Wang
  • View Affiliations / Copyright

    Affiliations: Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, P.R. China, State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204, P.R. China, Department of General Surgery, The First Affiliated Yijishan Hospital with Wannan Medical College, Wuhu 241001, P.R. China
  • Pages: 757-763
    |
    Published online on: May 19, 2014
       https://doi.org/10.3892/ijo.2014.2449
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Natural plant products occupy a very important position in the area of cancer chemotherapy. Many triterpenoid saponins have been proved as potential agents for chemoprevention and therapy of breast cancer. α-hederin, a monodesmosidic triterpenoid saponin distributed in Hedera or Nigella species, displays many biological activities. It is increasingly investigated for its promising anticancer potential since it has been shown to have cytotoxicity against several types of cancer cells. However, studies of α-hederin on breast cancer are limited, most of which focus on biological activity, while the mechanisms have not been widely reported yet. Previously, we purified and identified α-hederin from Clematis ganpiniana, a herb used in traditional Chinese medicine with antitumor action. In the present study, α-hederin showed strong inhibitory activity on the growth of breast cancer cells and induced apoptosis in these cells. α-hederin induced depolarization of mitochondrial membrane potential which released Apaf-1 and cytochrome c from the intermembrane space into the cytosol, where they promoted caspase-3 and caspase-9 activation. This is the first report on the growth inhibition and pro-apoptotic effects of α-hederin on breast cancer cells and the relative apoptosis pathways. It implied that triterpenoid saponin α-hederin could be a promising candidate for chemotherapy of breast cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar

2 

Ribeiro JT, Macedo LT, Curigliano G, et al: Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? Ann Oncol. 23:547–555. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Karikas GA: Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. J BUON. 15:627–638. 2010.PubMed/NCBI

4 

Cragg GM and Newman DJ: Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 6:182013.

5 

Wang TH, Wang HS and Soong YK: Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together. Cancer. 88:2619–2628. 2000. View Article : Google Scholar : PubMed/NCBI

6 

Ding Q, Yang LX, Yang HW, Jiang C, Wang YF and Wang S: Cytotoxic and antibacterial triterpenoids derivatives from Clematis ganpiniana. J Ethnopharmacol. 126:382–385. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Podolak I, Galanty A and Sobolewska D: Saponins as cytotoxic agents: a review. Phytochem Rev. 9:425–474. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Augustin JM, Kuzina V, Andersen SB and Bak S: Molecular activities, biosynthesis and evolution of triterpenoid saponins. Phytochemistry. 72:435–457. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Bishayee A, Ahmed S, Brankov N and Perloff M: Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front Biosci (Landmark Ed). 16:980–996. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Patlolla JMR and Rao CV: Triterpenoids for cancer prevention and treatment: Current status and future prospects. Curr Pharm Biotechnol. 13:147–155. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Calabrese AI: Letter: Antiviral activity of hederin. J Pharm Sci. 64:VIII1975. View Article : Google Scholar : PubMed/NCBI

12 

Gepdiremen A, Mshvildadze V, Suleyman H and Elias R: Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine. 12:440–444. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Gulcin I, Mshvildadze V, Gepdiremen A and Elias R: Antioxidant activity of saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F. Planta Med. 70:561–563. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Ridoux O, Di Giorgio C, Delmas F, et al: In vitro antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A(1), in association with pentamidine and amphotericin B. Phytother Res. 15:298–301. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Trute A, Gross J, Mutschler E and Nahrstedt A: In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med. 63:125–129. 1997. View Article : Google Scholar : PubMed/NCBI

16 

Quetin-Leclercq J, Elias R, Balansard G, Bassleer R and Angenot L: Cytotoxic activity of some triterpenoid saponins. Planta Med. 58:279–281. 1992. View Article : Google Scholar : PubMed/NCBI

17 

Danloy S, Quetin-Leclercq J, Coucke P, et al: Effects of alpha-hederin, a saponin extracted from Hedera helix, on cells cultured in vitro. Planta Med. 60:45–49. 1994. View Article : Google Scholar

18 

Rooney S and Ryan MF: Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res. 25:2199–2204. 2005.PubMed/NCBI

19 

Tian Z, Liu YM, Chen SB, et al: Cytotoxicity of two triterpenoids from Nigella glandulifera. Molecules. 11:693–699. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Yan LH, Xu LZ, Lin J, Yang SL and Feng YL: Triterpenoid saponins from the stems of Clematis parviloba. J Asian Nat Prod Res. 11:332–338. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Kumara SS and Huat BT: Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta Med. 67:29–32. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Feller G, Kugel A, Moonshine D, et al: African descents are more sensitive than European descents to the antitumor compounds alpha-hederin and kalopanaxsaponin I. Planta Med. 76:1847–1851. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Pasi S, Aligiannis N, Pratsinis H, Skaltsounis AL and Chinou IB: Biologically active triterpenoids from Cephalaria ambrosioides. Planta Med. 75:163–167. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Swamy SM and Huat BT: Intracellular glutathione depletion and reactive oxygen species generation are important in alpha-hederin-induced apoptosis of P388 cells. Mol Cell Biochem. 245:127–139. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Rooney S and Ryan MF: Modes of action of alpha-hederin and thymoquinone, active constituents of Nigella sativa, against HEp-2 cancer cells. Anticancer Res. 25:4255–4259. 2005.PubMed/NCBI

26 

Liu JJ, Lin M, Yu JY, Liu B and Bao JK: Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett. 300:105–114. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Shi Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell. 9:459–470. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Dias N and Bailly C: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol. 70:1–12. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Suen DF, Norris KL and Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Wang QF, Chen JC, Hsieh SJ, Cheng CC and Hsu SL: Regulation of Bcl-2 family molecules and activation of caspase cascade involved in gypenosides-induced apoptosis in human hepatoma cells. Cancer Lett. 183:169–178. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Wang J, Zhao XZ, Qi Q, et al: Macranthoside B, a hederagenin saponin extracted from Lonicera macranthoides and its anti-tumor activities in vitro and in vivo. Food Chem Toxicol. 47:1716–1721. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Park HM, Kim SJ, Kim JS and Kang HS: Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol. 50:2736–2741. 2012. View Article : Google Scholar

33 

Chun J, Ha IJ and Kim YS: Antiproliferative and apoptotic activities of triterpenoid saponins from the roots of Platycodon grandiflorum and their structure-activity relationships. Planta Med. 79:639–645. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Mo S, Xiong H, Shu G, et al: Phaseoloideside E, a novel natural triterpenoid saponin identified from Entada phaseoloides, induces apoptosis in Ec-109 esophageal cancer cells through reactive oxygen species generation. J Pharmacol Sci. 122:163–175. 2013.PubMed/NCBI

35 

Wang CZ, Li XL, Wang QF, Mehendale SR, Fishbein AB, Han AH, Sun S and Yuan CS: The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep. 21:577–584. 2009.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cheng L, Xia T, Wang Y, Zhou W, Liang X, Xue J, Shi L, Wang Y, Ding Q, Wang M, Wang M, et al: The anticancer effect and mechanism of α-hederin on breast cancer cells. Int J Oncol 45: 757-763, 2014.
APA
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X., Xue, J. ... Wang, M. (2014). The anticancer effect and mechanism of α-hederin on breast cancer cells. International Journal of Oncology, 45, 757-763. https://doi.org/10.3892/ijo.2014.2449
MLA
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X., Xue, J., Shi, L., Wang, Y., Ding, Q., Wang, M."The anticancer effect and mechanism of α-hederin on breast cancer cells". International Journal of Oncology 45.2 (2014): 757-763.
Chicago
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X., Xue, J., Shi, L., Wang, Y., Ding, Q., Wang, M."The anticancer effect and mechanism of α-hederin on breast cancer cells". International Journal of Oncology 45, no. 2 (2014): 757-763. https://doi.org/10.3892/ijo.2014.2449
Copy and paste a formatted citation
x
Spandidos Publications style
Cheng L, Xia T, Wang Y, Zhou W, Liang X, Xue J, Shi L, Wang Y, Ding Q, Wang M, Wang M, et al: The anticancer effect and mechanism of α-hederin on breast cancer cells. Int J Oncol 45: 757-763, 2014.
APA
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X., Xue, J. ... Wang, M. (2014). The anticancer effect and mechanism of α-hederin on breast cancer cells. International Journal of Oncology, 45, 757-763. https://doi.org/10.3892/ijo.2014.2449
MLA
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X., Xue, J., Shi, L., Wang, Y., Ding, Q., Wang, M."The anticancer effect and mechanism of α-hederin on breast cancer cells". International Journal of Oncology 45.2 (2014): 757-763.
Chicago
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X., Xue, J., Shi, L., Wang, Y., Ding, Q., Wang, M."The anticancer effect and mechanism of α-hederin on breast cancer cells". International Journal of Oncology 45, no. 2 (2014): 757-763. https://doi.org/10.3892/ijo.2014.2449
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team